Morning dosing for dolutegravir-related insomnia and sleep disorders
- PMID: 28762661
- DOI: 10.1111/hiv.12540
Morning dosing for dolutegravir-related insomnia and sleep disorders
Comment in
-
Reply to Letter 'Morning dosing for dolutegravir-related insomnia and sleep disorders' by Capetti et al.HIV Med. 2018 May;19(5):e60-e61. doi: 10.1111/hiv.12539. Epub 2017 Aug 29. HIV Med. 2018. PMID: 28851009 No abstract available.
Comment on
-
Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients.HIV Med. 2017 Jan;18(1):56-63. doi: 10.1111/hiv.12468. Epub 2016 Nov 10. HIV Med. 2017. PMID: 27860104
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical